Serina hits early milestone in Parkinson’s trial
With first patient cohort completed, Serina is advancing therapy that could make Parkinson’s treatment steadier for the aging brain. Parkinson’s treatment has largely been about replacing what the brain is losing: dopamine, the chemical messenger that helps coordinate movement. However, researchers
<p>With first patient cohort completed, Serina is advancing therapy that could make Parkinson’s treatment steadier for the aging brain. Parkinson’s treatment has largely been about replacing what the brain is losing: dopamine, the chemical messenger that helps coordinate movement. However, researchers </p>